<unk> , sold under the brand name Pifeltro, is a non-nucleoside reverse transcriptase inhibitor medication developed by Merck & Co. for use in the treatment of HIV/AIDS.<unk>  was approved for medical use in the United States in August 2018.
Doravirine
Saquinavir
Ritonavir
Amprenavir
Entecavir
Fosamprenavir
Fostemsavir
Abacavir